Company: EUDAW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001493152-25-011729
Chunk: 15

Company: EUDA Health Holdings Ltd
Filing Date: 2025-08-08
Form: 424B5
Chunk 15
---
. Without an active trading market, the liquidity of the Convertible Note will be limited.

Our failure to meet the Nasdaq listing requirements could result in a delisting our ordinary shares.

If we fail to satisfy the continued listing requirements of the Nasdaq Capital Market, such as the corporate governance requirements or the minimum closing bid price requirement, Nasdaq may take steps to delist our ordinary shares. Such a delisting would likely have a negative effect on the price of our ordinary shares and would impair our stockholders’ ability to sell or purchase ordinary shares when they wish to do so. In the event of a delisting, we can provide no assurance that any action taken by us to regain compliance with listing requirements would allow our ordinary shares to become listed again, stabilize the market price or improve the liquidity of our ordinary shares, or prevent future non-compliance with Nasdaq listing requirements.

| S-9 |

<div align='center'>FORWARD-LOOKING STATEMENTS</div>

This prospectus supplement, the accompanying prospectus, and the documents that we incorporate by reference herein and therein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended or the Exchange Act. Forward-looking statements include those that express plans, anticipation, intent, contingency, goals, targets, or future development and/or otherwise are not statements of historical fact. Any forward-looking statements are based on our current expectations and projections about future events and are subject to risks and uncertainties known and unknown that could cause actual results and developments to differ materially from those expressed or implied in such statements.

Some of these statements include, among others, statements about:

| ● | expectations                                                                                    
 regarding the Company’s strategies and future financial performance, including its              
 future business plans or objectives, prospective performance and opportunities and competitors, 
 revenues, products and services, pricing, operating expenses, market trends, liquidity, cash    
 flows and uses of cash, capital expenditures;                                                   |
| ● | the                                                                                             
 ability to grow and manage growth profitably;                                                   |
| ● | macro-economic                                                                                  
 conditions in Singapore, Malaysia, and other Asian countries;                                   |
| ● | the                                                                                             
 likelihood that the Company may be adversely affected by other economic, business, and/or       
 competitive factors;                                                                            |
| ● | risks                                                                                           
 relating to the uncertainty of the projected financial information with respect to the Company; |
| ● | risks